Onuigbo M - Search Results

1

Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR. Palmer BF, et al. Among authors: onuigbo m. Mayo Clin Proc. 2021 Mar;96(3):744-762. doi: 10.1016/j.mayocp.2020.06.014. Epub 2020 Nov 5. Mayo Clin Proc. 2021. PMID: 33160639 Free article. Review.

2

Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure.

Rafique Z, Weir MR, Onuigbo M, Pitt B, Lafayette R, Butler J, Lopes M, Farnum C, Peacock WF. Rafique Z, et al. Among authors: onuigbo m. J Manag Care Spec Pharm. 2017 Apr;23(4-a Suppl):S10-S19. doi: 10.18553/jmcp.2017.23.4-a.s10. J Manag Care Spec Pharm. 2017. PMID: 28485203 Free PMC article.

3

Evidence-based treatment of hypertension in patients with diabetes mellitus.

Onuigbo M, Weir MR. Onuigbo M, et al. Diabetes Obes Metab. 2003 Jan;5(1):13-26. doi: 10.1046/j.1463-1326.2003.00222.x. Diabetes Obes Metab. 2003. PMID: 12542721 Review. No abstract available.

4

Pretransplant serum C-reactive protein and the risk of chronic allograft nephropathy in renal transplant recipients: a pilot case-control study.

Fink JC, Onuigbo MA, Blahut SA, Christenson RH, Mann D, Bartlett ST, Weir MR. Fink JC, et al. Am J Kidney Dis. 2002 May;39(5):1096-101. doi: 10.1053/ajkd.2002.32794. Am J Kidney Dis. 2002. PMID: 11979355

5

RAAS inhibition and cardiorenal syndrome.

Onuigbo MA. Onuigbo MA. Curr Hypertens Rev. 2014;10(2):107-11. doi: 10.2174/1573402111666141231144228. Curr Hypertens Rev. 2014. PMID: 25549841 Review.

6

Gender differences in responsiveness to erythropoietin.

Onuigbo M. Onuigbo M. Am J Kidney Dis. 2002 Feb;39(2):442-3. doi: 10.1053/ajkd.2002.31195. Am J Kidney Dis. 2002. PMID: 11840394 No abstract available.

7

Case Study: The Weighty Issue of Treatment Options for Obese Dialysis Patients.

de Waal D, Onuigbo M, Golper TA. de Waal D, et al. Among authors: onuigbo m. J Ren Nutr. 2024 Apr 27:S1051-2276(24)00065-7. doi: 10.1053/j.jrn.2024.04.004. Online ahead of print. J Ren Nutr. 2024. PMID: 38685393

8

Renin-Angiotensin-Aldosterone System Blockade (RAASB) After Acute Kidney Injury: The Controversy Thickens on If and When to Discontinue RAASB.

Onuigbo MA. Onuigbo MA. Cureus. 2023 Nov 28;15(11):e49571. doi: 10.7759/cureus.49571. eCollection 2023 Nov. Cureus. 2023. PMID: 38161827 Free PMC article.

9

Chronic Kidney Disease Burden in Low-Resource Settings: Regional Perspectives.

Ulasi II, Awobusuyi O, Nayak S, Ramachandran R, Musso CG, Depine SA, Aroca-Martinez G, Solarin AU, Onuigbo M, Luyckx VA, Ijoma CK. Ulasi II, et al. Among authors: onuigbo m. Semin Nephrol. 2022 Sep;42(5):151336. doi: 10.1016/j.semnephrol.2023.151336. Epub 2023 Apr 12. Semin Nephrol. 2022. PMID: 37058859 Free article. Review.

10

A Four-Year Report on Renal Outcomes Following the Elective Withdrawal of Long-Term Renin-Angiotensin-Aldosterone Blockade in a Cohort of Patients With Otherwise Inexplicable New-Onset and Progressive Acute Kidney Injury.

Onuigbo MA. Onuigbo MA. Cureus. 2022 Oct 28;14(10):e30794. doi: 10.7759/cureus.30794. eCollection 2022 Oct. Cureus. 2022. PMID: 36447726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page